RNS Number : 5602I
Fiinu PLC
21 November 2025
 

21 November 2025

 

Fiinu Plc

("Fiinu", the "Company" or the "Group")

 

Share Purchase by Employee Benefit Trust

 

Fiinu plc (AIM: BANK) announces that, further to its announcement on 17 November 2025, it has been informed by Equiniti Trust (Jersey) Limited (the "Trustee"), which administers the Fiinu Group plc Employee Benefit Trust ("EBT"), has made its first market purchase (the "Market Purchase") of ordinary shares of 10p each in the Company ("Ordinary Shares") for the benefit of the EBT, and to satisfy the future vesting of awards under the Company's share incentive schemes.

 

The Trustee purchased 284,090 Ordinary Shares at a price of 8.8p per Ordinary Share on 19 November 2025. Market Purchases may continue, subject to the independent Trustee's absolute discretion in respect of trading decisions, in consultation with its broker, to satisfy future requirements under the EBT.

 

 

For further information, please contact:  

Fiinu Plc

Dr. Marko Sjoblom - CEO

Tel: +44 (0) 1932 629 532



SPARK Advisory Partners Limited (Nomad)

Mark Brady / Angus Campbell

Tel: +44 (0) 203 368 3550

Email: fiinu@sparkapl.com



Marex Financial (Joint Broker)

Angelo Sofocleous / Keith Swann / Matt Bailey

Tel: +44 (0) 207 655 6000

Email: corporate@marex.com



Oberon Investment Limited (Joint Broker)

Nick Lovering / Adam Pollock / Mike Seabrook

Tel: +44 (0)203 179 5300

 


Brazil (Financial PR)

Joshua van Raalte / Jamie Lester /Christine Webb

Tel: +44 (0) 207 785 7383

 

For more information, please visit www.fiinuplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FUREAEFFASASFFA